Ighm/Ighd-KO
Nomenclature
C57BL/6Smoc-Ighmem1Ighdem1Smoc
Cat. NO.
NM-KO-200610
Strain State
Repository Live
Gene Summary
Gene Symbol
Model Description
Validation Data
Fig1. Confirmation of Ighm knockout and B cell development in blood in Ighm/Ighd-KO mice by FACS.
Fig2. T cell and NK cell lineages development in blood in Ighm/Ighd-KO mice by FACS.
Fig3. In vivo anti-tumor efficacy in Ighm/Ighd-KO mice bearing MC38 syngeneic tumors.
Fig4. The impact of B cell depeltion on the anti-tumor efficacy in Ighm/Ighd-KO mice bearing mPA6115 tumors (GEMM-derived homograft).
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more